“We found this pattern surprising,” said Dr. Timothy Daskivich, director of Urologic Oncology Research for the Cedars-Sinai ...

Huntsman Cancer Institute’s Urologic Cancers Program provides comprehensive, compassionate, state-of-the-art care for people with these cancers. Our experts treat and diagnose all types of urologic ...

Judith T. Fullerton, PhD, CNM, FACNM, is Senior Technical Advisor for Monitoring & Evaluation, Project Concern International, San Diego, CA. She is also an international consultant for programs in ...

This advertisement has not loaded yet, but your article continues below. The salmon are quickly returning to spawn in cool creeks that have been cut off to them for generations Researchers at ...

Understanding and planning for the public's psychological response to terrorism has far-reaching implications for the practical management of a bioterrorist event. Bioterrorism raises special ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

GLP-1 receptor agonist use in the perioperative period should be based on shared decision-making of patient and care teams. Libby Baney, Senior Advisor to ASOP Global and a partner at Faegre ...

The decision comes after a pre-specified futility analysis determined that it was unlikely that the study would meet its primary end point.

The phase 1/2a SECuRE trial is evaluating the safety and efficacy of 67Cu-SAR-bisPSMA in the treatment of patients with mCRPC.